Novavax, Inc. (NVAX)
6.705
-0.02
(-0.22%)
USD |
NASDAQ |
Dec 31, 13:53
Novavax Market Cap: 1.090B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 142.00B |
| Moderna, Inc. | 11.60B |
| Merck & Co., Inc. | 262.10B |
| Arcturus Therapeutics Holdings, Inc. | 172.46M |
| Denali Therapeutics, Inc. | 2.589B |
Market Cap Related Metrics
| PE Ratio | 3.791 |
| PS Ratio | 1.067 |
| Price | 6.705 |
| Earnings Yield | 26.38% |
| Operating PE Ratio | 2.725 |
| Normalized PE Ratio | 2.839 |